Chapter 725： [Nanobots that kill cancer cells]

On the second exhibition day of the Côte d'Azur Science and Technology Expo, the local tyrants from the Middle East led a delegation to see the goods today. Their arrival also attracted a lot of media attention and reports.

As soon as the local tyrants came, they were naturally regarded as guests by the sales department on the blue coast.

In the eyes of many people, these people wearing white robes and turbans are all "banknotes" that walk automatically, and these "banknotes" are now automatically going to Luo Sheng's pocket.

Seeing this group of people enter the city of galaxy, almost all of them are surprisingly unanimously envious of the blue coast, which is the rhythm of big business.

Sure enough, the local tyrants had just arrived in the morning, and in the afternoon there was definite news that business delegations sent by many Middle Eastern countries signed a large contract with the Blue Coast Company.

The company will provide these customers in the Middle East with graphene membrane filtration seawater desalination system solutions within the next three years. This new technology-based seawater desalination system will be delivered and put into use at the latest in 2021.

The scale of demand of the big tyrants is different, and the amount of contract orders is also different.

The Côte d’Azur and Sate signed the largest contract value with USD 3.3 billion, followed by Qatar with USD 2.7 billion, followed by the UAE with USD 2.2 billion.

There are relatively few other local tyrants in the Middle East, but the entire group of local tyrants in the Middle East smashed in at 11.5 billion today.

Although it is impossible for the Côte d'Azur Lab to recover the cost of graphene materials based on the order distance alone, it is only one of the application scenarios of graphene materials.

The most important thing is the sustained profitability effect. The graphene membrane filter material is a consumable. This technology belongs to the blue coast, which means that the local tyrants will have to continue to purchase when they run out in the future.

Although you can't make a sudden profit, the key point is to be able to guarantee income during droughts and floods. As long as the local tyrant's "money ability" does not disappear, the money can be made steadily. How can the local tyrant's "money ability" last for decades.

Earning a few decades is not only enough, but the subsequent profits are also full of rhythm.

In fact, the contract list of more than ten billion US dollars is an astronomical figure in itself, but it is a little bit less for the annual income of the Côte d’Azur.

But that is also a $11.5 billion order, which can definitely be called a super big order.

The outside world knows that the day after day of deep plowing on the Côte d’Azur for nearly 15 years has finally blossomed and bear fruit today, and it’s time to harvest.

It's impossible to say that you don't envy, but you won't be envious.

...

"The strong are always strong, the size of the blue coast and the courage and foresight of the helm, the formation of the'siphon effect' almost extends his tentacles to the major boundaries of the scientific and technological field. In the future...maybe only join This system can survive."

A middle-aged man in a suit and leather shoes looked around the expo and couldn't help but feel emotional. His name is Ding Xian, a manager of a venture capital institution.

There are too many people from investment institutions at the Expo site. Almost all of the technology companies participating in the fair are relatively promising start-up companies, which are favored by venture capital institutions.

The reason is also very simple. These start-up companies are basically companies invested by Côte d'Azur or Shengfeng Capital. They are either subsidiaries or affiliated companies. It also means that these companies have been screened by Luo Sheng, the world's first person in technology.

He is optimistic, investors of course favor it more, which is equivalent to helping them through a screening.

"Look over there."

Ding Xian said to the assistant secretary who followed him and walked towards the medical equipment exhibition area.

After a while, the two came to a very popular exhibition area. In addition to some technology enthusiasts and tourists, there were also many so-called elites in suits. They were basically industry practitioners or VCs. This exhibition area It is a start-up company strategically invested by the Blue Coast-Hongrui Medical.

The founders are two young men named Zhao Yu and Lu Zhengyang, both of whom are young doctors in their 30s. They both graduated from Rice University in North America and belonged to the same laboratory during the school. Later they decided to return to China to start a business.

Originally, they didn’t want to return to China to start a business. The environment abroad is better, but in the end one of the biggest factors that motivated them to return to start a business in China is that there is a big domestic technology guy named Luo Sheng, a technology company called Blue Coast, and one An investment institution called Shengfeng Capital.

Compared with other institutions or entrepreneurial environments, Luo Sheng and its subsidiaries are really investing in the field of science and technology instead of collecting money, they are really spending money constantly.

This gave them great confidence. In fact, neither Azure Coast nor Shengfeng Capital failed their expectations. Zhao Yu personally found the person from Shengfeng Capital. As a result, half of his story was told that day. Arrived 4 million yuan angel round investment.

Last year, Zhao Yu and Lu Zhengyang jointly published their latest nanomedicine research results in the journal Nature in the name of the Hongrui Medical Company that they co-founded.

This is what they claimed at the Expo today to be a nanorobot that can kill cancer cells.

At this moment, Ding Xian stood in the crowd silently watching Lu Zhengyang, who came here to promote his own products, introduce their results.

"The length of the nanorobot developed by our company is only one-fifty thousandth of the diameter of a human hair. It can be driven by light and drilled in advance with high-speed spin at 3 million times per second. Specify the cancer cells, so that the inside of the cancer cells will be overwhelmed. It only takes one to three minutes to physically and completely kill the cancer cells."

Lu Zhengyang's introduction undoubtedly aroused the surprise of many people present, and most of them showed a surprised expression when they heard what he said.

The so-called nano-robots are of course invisible to the naked eye. Lu Zhengyang also showed it in his own exhibition area by playing videos in the laboratory and some microscopic display pictures.

An industry insider at the scene couldn’t help saying: “As you said, even cancer cells that are already super-drug resistant can’t withstand this kind of toss, UU reading that kind of nanorobot. What is the core of the drive?"

Faced with inquiries from industry insiders, Lu Zhengyang smiled and explained: “The core structure that acts as the driving core of this nanorobot's engine is a kind of rotor-like'atomic chain' that we call a'triple chain'. It is made of high-grade particles, which can move freely on the uneven surface of atoms, relying on the'driving shaft' of the'triple chain'."

The non-professional passers-by who were there eating melons could only feel unclear.

Hongrui Medical was established in early 2015. The concept of micro-molecular machines has not been popularized this year. It was only in 2016 that someone in this field won the Nobel Prize, and then it began to be popularized.

Zhao Yu and Lu Zhengyang had already developed the idea of ​​using molecular machine principles to develop nanorobots in 2014. It was precisely because of this opportunity that the two of them got to know each other, and the same-minded business made them decide to start a business together. I hope to use my professional knowledge and skills to make achievements in the field of micro-molecular machines.

This was the birth of Hongrui Medical.